Diagnosing Immune Checkpoint Inhibitor-Induced Myocarditis: Insights, Challenges, and Uncertainties
Recent advancements in immunotherapy have substantially improved overall survival and quality of life among patients with cancer. Notably, immune checkpoint inhibitors (ICIs) have emerged as a revolutionary strategy, particularly in the management of advanced cancers. However, the success of ICIs is...
        Saved in:
      
    
          | Main Authors: | Liang Lu, Xiyu Wang, Haodong Xu | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Compuscript Ltd
    
        2024-07-01 | 
| Series: | Cardiovascular Innovations and Applications | 
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0039 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis        
                          
 by: Jennifer Cautela, et al.
 Published: (2020-10-01)
- 
                
                    Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis        
                          
 by: Ryo Izumi, et al.
 Published: (2024-11-01)
- 
                
                    Modeling immune checkpoint inhibitor associated myocarditis in vitro and its therapeutic implications        
                          
 by: Garrett Jensen, et al.
 Published: (2024-12-01)
- 
                
                    Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series        
                          
 by: Joshua Longinow, et al.
 Published: (2023-02-01)
- 
                
                    Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration        
                          
 by: Zhijie Liu, et al.
 Published: (2022-06-01)
 
       